Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;23(9):R393-409.
doi: 10.1530/ERC-16-0130.

Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review

Sakine Sever  1 , Donna L White  2 , José M Garcia  3
Affiliations
Free PMC article

Is there an effect of ghrelin/ghrelin analogs on cancer? A systematic review

Sakine Sever et al. Endocr Relat Cancer. 2016 Sep.
Free PMC article

Abstract

Ghrelin is a hormone with multiple physiologic functions, including promotion of growth hormone release, stimulation of appetite and regulation of energy homeostasis. Treatment with ghrelin/ghrelin-receptor agonists is a prospective therapy for disease-related cachexia and malnutrition. In vitro studies have shown high expression of ghrelin in cancer tissue, although its role including its impact in cancer risk and progression has not been established. We performed a systematic literature review to identify peer-reviewed human or animal in vivo original research studies of ghrelin, ghrelin-receptor agonists, or ghrelin genetic variants and the risk, presence, or growth of cancer using structured searches in PubMed database as well as secondary searches of article reference lists, additional reviews and meta-analyses. Overall, 45 (73.8%) of the 61 studies reviewed, including all 11 involving exogenous ghrelin/ghrelin-receptor agonist treatment, reported either a null (no statistically significant difference) or inverse association of ghrelin/ghrelin-receptor agonists or ghrelin genetic variants with cancer risk, presence or growth; 10 (16.7%) studies reported positive associations; and 6 (10.0%) reported both negative or null and positive associations. Differences in serum ghrelin levels in cancer cases vs controls (typically lower) were reported for some but not all cancers. The majority of in vivo studies showed a null or inverse association of ghrelin with risk and progression of most cancers, suggesting that ghrelin/ghrelin-receptor agonist treatment may have a favorable safety profile to use for cancer cachexia. Additional large-scale prospective clinical trials as well as basic bioscientific research are warranted to further evaluate the safety and benefits of ghrelin treatment in patients with cancer.

Keywords: cachexia; cancer; ghrelin; in vivo; metastasis; tumor growth.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Physiologic effects of ghrelin. ACTH, adrenocorticotropic hormone; GH, growth hormone; PRL, prolactin. Adapted, under the terms of the Creative Commons Attribution License, from Delporte et al. 2013; additional data from Korbonits et al. 2004.
Figure 2
Figure 2
Systematic review flow diagram: in vivo research evidence of associations of ghrelin with cancer.
See this image and copyright information in PMC

References

    1. Akamizu T, Shinomiya T, Irako T, Fukunaga M, Nakai Y, Nakai Y, Kangawa K. 2005. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. Journal of Clinical Endocrinology and Metabolism 90 6–9. (10.1210/jc.2004-1640) - DOI - PubMed
    1. Ali S, Chen JA, Garcia JM. 2013. Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment. Current Opinion in Supportive and Palliative Care 7 368–375. (10.1097/SPC.0000000000000012) - DOI - PMC - PubMed
    1. Allen DB, Rundle AC, Graves DA, Blethen SL. 1997. Risk of leukemia in children treated with human growth hormone: review and reanalysis. Journal of Pediatrics 131 S32–S36. (10.1016/s0022-3476(97)70008-8) - DOI - PubMed
    1. Ataseven H, Bahcecioglu IH, Kuzu N, Yalniz M, Celebi S, Erensoy A, Ustundag B. 2006. The levels of ghrelin, leptin, TNF-α, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators of Inflammation 2006 78380 (10.1155/MI/2006/78380) - DOI - PMC - PubMed
    1. Aydin S, Karatas F, Geckil H. 2008. Simultaneous quantification of acylated and desacylated ghrelin in biological fluids. Biomedical Chromatography 22 1354–1359. (10.1002/bmc.1065) - DOI - PubMed

Publication types

LinkOut - more resources